 |
|
|
| |
A CLINICALLY MEANINGFUL DRUG-DRUG INTERACTION OBSERVED BETWEEN ZEPATIERTM (GRAZOPREVIR/ELBASVIR) AND STRIBILD® HIV FIXED-DOSE COMBINATION IN HEALTHY SUBJECTS
|
| |
| |
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
June 8-10, 2016, Washington, DC, USA
Hwa-Ping Feng1, Luzelena Caro1, Katherine M. Dunnington2, Zifang Guo1, Nadia Cardillo Marricco2, Dennis Wolford1, Laura Sterling2, Angela Mirzac2, Tamara Moore2, Marian Iwamoto1, Wendy W. Yeh1
1Merck & Co., Inc., Kenilworth, NJ 2Celerion, Inc., Lincoln, NE
|
| |
|
|
|
|
|
